相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach
J. H. Azambuja et al.
MOLECULAR NEUROBIOLOGY (2020)
Immunologic and immunogenomic aspects of tumor progression
Andrea Ladanyi et al.
SEMINARS IN CANCER BIOLOGY (2020)
Adenosine signaling and the immune system: When a lot could be too much
Luca Antonioli et al.
IMMUNOLOGY LETTERS (2019)
Targeting the CD73-adenosine axis in immuno-oncology
David Allard et al.
IMMUNOLOGY LETTERS (2019)
Canonical and non-canonical adenosinergic pathways
E. Ferretti et al.
IMMUNOLOGY LETTERS (2019)
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
J. H. Azambuja et al.
MOLECULAR NEUROBIOLOGY (2019)
Reprint of Immunomodulatory effects of CD38-targeting antibodies
Niels W. C. J. van de Donk
IMMUNOLOGY LETTERS (2019)
A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy
Zheng Qiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
Hongmei Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110 and predicts poor prognosis
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling
Angela Yan et al.
JOURNAL OF NEUROSCIENCE (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Simone de Leve et al.
FRONTIERS IN IMMUNOLOGY (2019)
Extracellular nucleotides and nucleosides as signalling molecules
Anna Lisa Giuliani et al.
IMMUNOLOGY LETTERS (2019)
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
Mohammad H. Kazemi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation
Seyyed Mehdi Jafari et al.
CELLULAR ONCOLOGY (2018)
Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
Tao Jiang et al.
BMC CANCER (2018)
T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients
P. Di Gennaro et al.
CANCER LETTERS (2018)
Modulation of innate and adaptive immunity by P2X ion channels
Francesco Di Virgilio et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression
Jorgen Kjaergaard et al.
JOURNAL OF IMMUNOLOGY (2018)
PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART
Pier Andrea Borea et al.
PHYSIOLOGICAL REVIEWS (2018)
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+
F. Morandi et al.
ONCOIMMUNOLOGY (2018)
Targeting adenosine for cancer immunotherapy
Robert D. Leone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence
M. -N. Theodoraki et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection
Daniela F. Passos et al.
PURINERGIC SIGNALLING (2018)
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Kevin Sek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
Andrea M. Chambers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Induction of antiinflammatory purinergic signaling in activated human iNKT cells
Jennifer C. Yu et al.
JCI INSIGHT (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
Extracellular purines, purinergic receptors and tumor growth
F. Di Virgilio et al.
ONCOGENE (2017)
Cellular Migration Ability Is Modulated by Extracellular Purines in Ovarian Carcinoma SKOV-3 Cells
A. S. Martinez-Ramirez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
Farhad Jadidi-Niaragh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
Si-Rui Ma et al.
MOLECULAR CANCER (2017)
Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
Samaneh Arab et al.
TUMOR BIOLOGY (2017)
Glioma sensitive or chemoresistant to temozolomide differentially modulate macrophage protumor activities
Juliana H. Azarnbuja et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma
Yihong Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
Luca Antonio et al.
DRUG DISCOVERY TODAY (2017)
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Martin Turcotte et al.
CANCER RESEARCH (2017)
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
Josephine Salimu et al.
JOURNAL OF EXTRACELLULAR VESICLES (2017)
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Arabella Young et al.
CANCER RESEARCH (2017)
CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity
Zhao-wei Gao et al.
BMC CANCER (2017)
Purinergic Signaling in the Cardiovascular System
Geoffrey Burnstock
CIRCULATION RESEARCH (2017)
Purinergic Signalling and Neurological Diseases: An Update
Geoffrey Burnstock
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
The A2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism
Christina Molck et al.
CANCER LETTERS (2016)
Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Purinergic Signalling and Endothelium
Geoffrey Burnstock
CURRENT VASCULAR PHARMACOLOGY (2016)
Exosomes and tumor-mediated immune suppression
Theresa L. Whiteside
JOURNAL OF CLINICAL INVESTIGATION (2016)
CD73 Inhibition Shifts Cardiac Macrophage Polarization toward a Microbicidal Phenotype and Ameliorates the Outcome of Experimental Chagas Cardiomyopathy
Nicolas Eric Ponce et al.
JOURNAL OF IMMUNOLOGY (2016)
Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration
Patrycja Koszalka et al.
PLOS ONE (2016)
Adenosine arrests breast cancer cell motility by A3 receptor stimulation
Carola Ledderose et al.
Purinergic Signalling (2016)
Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
Farhad Jadidi-Niaragh et al.
TUMOR BIOLOGY (2016)
Targeting CD73 in the tumor microenvironment with MEDI9447
Carl M. Hay et al.
ONCOIMMUNOLOGY (2016)
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
Itsaso Montalban del Barrio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation
Elizabeth A. Vecchio et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line
Mehdi Nikbakht Dastjerdi et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2016)
Adenosine A2b receptor promotes progression of human oral cancer
Hiroki Kasama et al.
BMC CANCER (2015)
P2X Receptors and Inflammation
Francesco Virgilio
CURRENT MEDICINAL CHEMISTRY (2015)
Involvement of Purinergic System in the Release of Cytokines by Macrophages Exposed to Glioma-Conditioned Medium
Leticia Scussel Bergamin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation
Fabio Morandi et al.
JOURNAL OF IMMUNOLOGY (2015)
Purinergic signalling during development and ageing
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2015)
Blood cells: an historical account of the roles of purinergic signalling
Geoffrey Burnstock
PURINERGIC SIGNALLING (2015)
The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma
Bin Zhang et al.
TUMOR BIOLOGY (2015)
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Ecto-5′-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model
Angelica R. Cappellari et al.
PLOS ONE (2015)
The A3 Adenosine Receptor: History and Perspectives
Pier Andrea Borea et al.
PHARMACOLOGICAL REVIEWS (2015)
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal et al.
CANCER RESEARCH (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Macrophage heterogeneity in tissues: phenotypic diversity and functions
Siamon Gordon et al.
IMMUNOLOGICAL REVIEWS (2014)
Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors
Ester Sciaraffia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells
Wakako Kaji et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2014)
Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo
Patrycja Koszalka et al.
ONCOLOGY REPORTS (2014)
Purinergic signalling in the reproductive system in health and disease
Geoffrey Burnstock
PURINERGIC SIGNALLING (2014)
Purinergic signalling and immune cells
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2014)
Targeting Cancer-Derived Adenosine: New Therapeutic Approaches
Arabella Young et al.
CANCER DISCOVERY (2014)
Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
Melanie Mediavilla-Varela et al.
CANCER BIOLOGY & THERAPY (2013)
CD73 and adenosine generation in the creation of regulatory microenvironments
F. S. Regateiro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
The stimulation of A3 adenosine receptors reduces bone-residing breast cancer in a rat preclinical model
Katia Varani et al.
EUROPEAN JOURNAL OF CANCER (2013)
CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+ T cells contributes to their regulatory function
Lesley Ann Smyth et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
Christopher James Ferrante et al.
INFLAMMATION (2013)
5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells
Claudia Quezada et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
Mikkel G. Terp et al.
JOURNAL OF IMMUNOLOGY (2013)
A3 Adenosine Receptor Mediates Apoptosis in In Vitro RCC4-VHL Human Renal Cancer Cells by Up-Regulating AMID Expression
Hisao Nagaya et al.
JOURNAL OF UROLOGY (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms
Anke C. Schiedel et al.
PURINERGIC SIGNALLING (2013)
A2B adenosine receptor blockade inhibits growth of prostate cancer cells
Qiang Wei et al.
PURINERGIC SIGNALLING (2013)
Purinergic signalling and cancer
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2013)
Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
Xiao-Xia Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Adenosine and prostaglandin E-2 production by human inducible regulatory T cells in health and disease
Theresa L. Whiteside et al.
FRONTIERS IN IMMUNOLOGY (2013)
Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
Raffaella Iannone et al.
NEOPLASIA (2013)
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein et al.
ONCOIMMUNOLOGY (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
Regulation of Macrophage Function by Adenosine
Gyorgy Hasko et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A3 Adenosine Receptor Mediates Apoptosis in 5637 Human Bladder Cancer Cells by Gq Protein/PKC-Dependent AIF Upregulation
Takeshi Kanno et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Adenosine Induces Apoptosis in SBC-3 Human Lung Cancer Cells through A3 Adenosine Receptor-Dependent AMID Upregulation
Takeshi Kanno et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
Bertrand Allard et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Caglar Cekic et al.
JOURNAL OF IMMUNOLOGY (2012)
The Adenosine A3 Receptor Agonist Cl-IB-MECA Induces Cell Death Through Ca2+/ROS-Dependent Down Regulation of ERK and Akt in A172 Human Glioma Cells
Thae Hyun Kim et al.
NEUROCHEMICAL RESEARCH (2012)
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
Rafael Fernandes Zanin et al.
PLOS ONE (2012)
Cellular function and molecular structure of ecto-nucleotidases
Herbert Zimmermann et al.
PURINERGIC SIGNALLING (2012)
CD73: a potent suppressor of antitumor immune responses
Paul. A. Beavis et al.
TRENDS IN IMMUNOLOGY (2012)
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The minimal important difference of exercise tests in severe COPD
M. A. Puhan et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway
Mahmoud Aghaei et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2011)
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
K. M. Dwyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells
De-Fu Ma et al.
HUMAN PATHOLOGY (2010)
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Differential ectonucleotidase expression in human bladder cancer cell lines
Joseli Stella et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Purinergic signalling: past, present and future
G. Burnstock
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
In vitro induction of T cells that are resistant to A(2) adenosine receptor-mediated immunosuppression
Akio Ohta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
NK cell-mediated cytotoxicity modulation by A2 adenosine receptor agonist in different mammalian species
M. Kuldova et al.
FOLIA MICROBIOLOGICA (2009)
CI-IB-MECA Enhances TRAIL-Induced Apoptosis via the Modulation of NF-κB Signalling Pathway in Thyroid Cancer Cells
Silvana Morello et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Adenosine Blocks IFN-γ-Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation
Kimberly E. Barnholt et al.
JOURNAL OF IMMUNOLOGY (2009)
Adenosine and IFN-α synergistically increase IFN-γ production of human NK cells
Florian Jeffe et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin
Stefania Merighi et al.
NEOPLASIA (2009)
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
Dima L. Diab et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
CD73 participates in cellular multiresistance program and protects against TRAIL-Induced apoptosis
Andrey Mikhailov et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
Luci Bavaresco et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion
Xiuling Zhi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells
Stefania Merighi et al.
MOLECULAR PHARMACOLOGY (2007)
Overexpression of Ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix
Ping Zhou et al.
CANCER BIOLOGY & THERAPY (2007)
Shaping of monocyte and macrophage function by adenosine receptors
Gyorgy Hasko et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
Courtney M. Lappas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells
Anna Lokshin et al.
CANCER RESEARCH (2006)
Adenosine inhibits tumor necrosis factor-α release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor
LM Kreckler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells
EJ Lee et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
AA Erdmann et al.
BLOOD (2005)
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
S Minguet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB
P Fishman et al.
ONCOGENE (2004)
Expression of A3 adenosine receptors in human lymphocytes:: Up-regulation in T cell activation
S Gessi et al.
MOLECULAR PHARMACOLOGY (2004)
An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines
M Panjehpour et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes:: Role of cyclic adenosine 3',5'-monophosphate and phosphatases
H Zhang et al.
JOURNAL OF IMMUNOLOGY (2004)
Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms
G Haskó et al.
FASEB JOURNAL (2000)
分享论文
